JSSH
J. Safra Sarasin Holding Portfolio holdings
AUM
$5.79B
1-Year Return
19.4%
This Quarter Return
-2.2%
1 Year Return
+19.4%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$5.52B
AUM Growth
-$373M
(-6.3%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-2.02%
Top 10 Holdings %
Top 10 Hldgs %
24.5%
Holding
521
New
60
Increased
146
Reduced
229
Closed
40
Top Buys
| 1 |
Brown-Forman Class B
BF.B
|
+$33.5M |
| 2 |
Republic Services
RSG
|
+$32.4M |
| 3 |
Baker Hughes
BKR
|
+$27.9M |
| 4 |
Acuity Brands
AYI
|
+$20.1M |
| 5 |
AbbVie
ABBV
|
+$20M |
Top Sells
| 1 |
UBS Group
UBS
|
+$58.9M |
| 2 |
Microsoft
MSFT
|
+$25.9M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$25.2M |
| 4 |
IBM
IBM
|
+$24.4M |
| 5 |
Microchip Technology
MCHP
|
+$21.2M |
Sector Composition
| 1 | Technology | 27.66% |
| 2 | Financials | 12.99% |
| 3 | Industrials | 12.53% |
| 4 | Healthcare | 12.11% |
| 5 | Consumer Discretionary | 11.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Biogen
BIIB
$20.7B
| $1.37M | 0.02% |
10,009
-52,864
| -84% | -$7.23M |
|
277
Target
TGT
$41.6B
| $1.36M | 0.02% |
13,069
-14,402
| -52% | -$1.5M |
|
278
Bristol-Myers Squibb
BMY
$95.1B
| $1.34M | 0.02% |
21,990
+3,457
| +19% | +$211K |
|
279
Cognizant
CTSH
$34.8B
| $1.33M | 0.02% |
17,423
-2,790
| -14% | -$213K |
|
280
Humana
HUM
$37.3B
| $1.33M | 0.02% |
5,013
-954
| -16% | -$252K |
|
281
Charles River Laboratories
CRL
$7.97B
| $1.32M | 0.02% |
8,783
+540
| +7% | +$81.3K |
|
282
Enel Chile
ENIC
$4.95B
| $1.3M | 0.02% |
397,991
-8,306
| -2% | -$27.2K |
|
283
Qorvo
QRVO
$8.5B
| $1.28M | 0.02% |
17,636
-4,028
| -19% | -$292K |
|
284
Clearway Energy Class C
CWEN
$3.34B
| $1.27M | 0.02% |
42,111
-812
| -2% | -$24.6K |
|
285
iShares MSCI China ETF
MCHI
$8.04B
| $1.24M | 0.02% |
22,836
+10,000
| +78% | +$544K |
|
286
Best Buy
BBY
$16.3B
| $1.24M | 0.02% |
16,842
-27,836
| -62% | -$2.05M |
|
287
Open Text
OTEX
$8.59B
| $1.23M | 0.02% |
48,766
-5,322
| -10% | -$134K |
|
288
Henry Schein
HSIC
$8.21B
| $1.22M | 0.02% |
17,782
-4,316
| -20% | -$296K |
|
289
Jabil
JBL
$22.4B
| $1.21M | 0.02% |
8,903
-3,187
| -26% | -$434K |
|
290
Golub Capital BDC
GBDC
$3.95B
| $1.21M | 0.02% |
80,000
| – | – |
|
291
Cheniere Energy
LNG
$51.3B
| $1.2M | 0.02% |
5,197
-511
| -9% | -$118K |
|
292
Coterra Energy
CTRA
$18.2B
| $1.17M | 0.02% |
40,620
-5,144
| -11% | -$149K |
|
|
ITCI
293
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.16M | 0.02% |
8,799
-21,765
| -71% | -$2.87M |
|
294
Citizens Financial Group
CFG
$22.3B
| $1.16M | 0.02% |
28,326
+3,767
| +15% | +$154K |
|
295
VanEck Gold Miners ETF
GDX
$20.2B
| $1.16M | 0.02% |
25,215
+2,600
| +11% | +$120K |
|
296
Vale
VALE
$44.6B
| $1.15M | 0.02% |
115,200
| – | – |
|
297
Teleflex
TFX
$5.75B
| $1.14M | 0.02% |
8,263
-130
| -2% | -$18K |
|
298
Akamai
AKAM
$11.3B
| $1.14M | 0.02% |
14,110
-1,255
| -8% | -$101K |
|
299
Axsome Therapeutics
AXSM
$6.45B
| $1.13M | 0.02% |
+9,660
| New | +$1.13M |
|
300
Builders FirstSource
BLDR
$16.3B
| $1.12M | 0.02% |
8,987
+393
| +5% | +$49.1K |
|